John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
LifeMD
LFMD
$157M
| $532K | ﹤0.01% |
150,784
-216,636
| -59% | -$769K |
|
1977
Amcor
AMCR
$21.9B
| $531K | ﹤0.01% |
9,376
-81,388
| -90% | -$4.75M |
|
1978
Arrow Financial
AROW
$707M
| $530K | ﹤0.01% |
+17,340
| New | +$568K |
|
1979
Nuvation Bio
NUVB
$2.49B
| $528K | ﹤0.01% |
+100,339
| New | +$564K |
|
1980
Tanger
SKT
$4.42B
| $524K | ﹤0.01% |
30,500
-227,388
| -88% | -$3.95M |
|
1981
World Kinect Corp
WKC
$1.81B
| $524K | ﹤0.01% |
19,391
-108,112
| -85% | -$3M |
|
1982
Upbound Group
UPBD
$1.13B
| $522K | ﹤0.01% |
+20,731
| New | +$749K |
|
1983
Bar Harbor Bankshares
BHB
$660M
| $520K | ﹤0.01% |
18,169
-131
| -0.7% | -$3.9K |
|
|
UMPQ
1984
DELISTED
Umpqua Holdings Corp
UMPQ
| $515K | ﹤0.01% |
27,323
-52,170
| -66% | -$1.07M |
|
1985
NSTS Bancorp
NSTS
$68.8M
| $513K | ﹤0.01% |
+42,492
| New | +$523K |
|
1986
Aaon
AAON
$6.28B
| $510K | ﹤0.01% |
+13,734
| New | +$560K |
|
1987
iHeartMedia
IHRT
$415M
| $508K | ﹤0.01% |
26,820
-109,672
| -80% | -$2.19M |
|
|
RYM
1988
RYTHM Inc
RYM
$51.2M
| $507K | ﹤0.01% |
37
+21
| +131% | +$411K |
|
1989
Republic Bancorp
RBCAA
$1.85B
| $507K | ﹤0.01% |
+11,281
| New | +$539K |
|
1990
Globus Medical
GMED
$11.1B
| $506K | ﹤0.01% |
+6,855
| New | +$476K |
|
|
KRON
1991
DELISTED
Kronos Bio
KRON
| $505K | ﹤0.01% |
69,907
+16,911
| +32% | +$144K |
|
1992
Village Super Market
VLGEA
$653M
| $505K | ﹤0.01% |
+20,626
| New | +$476K |
|
1993
Hallador Energy
HNRG
$771M
| $500K | ﹤0.01% |
+142,917
| New | +$447K |
|
1994
HighPeak Energy
HPK
$995M
| $500K | ﹤0.01% |
22,538
+1,603
| +8% | +$31.5K |
|
|
AERI
1995
DELISTED
Aerie Pharmaceuticals
AERI
| $500K | ﹤0.01% |
54,967
+36,609
| +199% | +$282K |
|
1996
MetroCity Bankshares
MCBS
$1.01B
| $498K | ﹤0.01% |
21,196
+7,512
| +55% | +$189K |
|
1997
Spyre Therapeutics
SYRE
$9.47B
| $498K | ﹤0.01% |
8,664
+6,084
| +236% | +$511K |
|
1998
Home Bancorp
HBCP
$543M
| $497K | ﹤0.01% |
12,179
-257
| -2% | -$10.5K |
|
|
PLM
1999
DELISTED
PolyMet Mining Corp.
PLM
| $496K | ﹤0.01% |
+118,340
| New | +$340K |
|
2000
Amneal Pharmaceuticals
AMRX
$6.24B
| $495K | ﹤0.01% |
118,698
-156,021
| -57% | -$691K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.